chrisvoncsefalvay/vaers-outcomes huggingface dataset:
received my first dose of the moderna shot on March 31st/It's been 4 months since I received my first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (received my first dose of the moderna shot on March 31st/It's been 4 months since I received my first dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (received my first dose of the moderna shot on March 31st/It's been 4 months since I received my first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (received my first dose of the moderna shot on March 31st/It's been 4 months since I received my first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were not reported. No treatment medications were not provided.
Patient received a dose of .3 mL.  Recommended dose is .2 mL.  No adverse reaction was noted as of 12/21/2021.
patient received shot from a vial punctured more than 12 hours ago; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received shot from a vial punctured more than 12 hours ago) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040D21A and 017E21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SALBUTAMOL SULFATE (ALBUTEROL [SALBUTAMOL SULFATE]), COLECALCIFEROL (VITAMIN D3), OMEPRAZOLE and NAPROXEN for an unknown indication.   On 31-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received shot from a vial punctured more than 12 hours ago). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received shot from a vial punctured more than 12 hours ago) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant naproxen from April. HCP did not know if patient still takes it.  Treatment information was not provided.
This patient got vaccinated with his wife's needle that we gave the flu shot with without vaccine. Patient did get the High dose vaccine with the vaccine as soon as error was discovered. This was a needle stick but wife concerned that she had hepatitis when she was 7 years old and didn't know if that was a concern since he got poked with the same needle as his wife. Patient did not have any adverse effect as of yet
At 9:05 am client states she felt shortness of breath and her heart racing.  Vital signs obtained by EMS, BP 135/83, pulse 90, Report O2 sat 99%, pulse 92. Client states she is feeling better.  EMS discharge client. Client left vaccine site at 9:10 am.
Covid Arm (itchy rash, hot to the touch), located on the left arm, a few inches below injection site.
Patient came in on Saturday 12/12/15 at 5:45pm two days after receiving the vaccine with a swollen, red, painful injection site.  She also complained of a headache.  I told her she may be having a mild allergic reaction to the vaccine or one of its ingredients and suggested she take Benadryl and ibuprofen for the swelling and pain, respectively as well as recommended a cold pack being applied to the swollen area for about 20 minutes to relieve some of the swelling as well.
Decreased appetite (using slim fast); Feeling not like myself; Hair thinnning; Increased tiredness; COVID infection (delta variant); This spontaneous case was reported by an other health care professional and describes the occurrence of DECREASED APPETITE (Decreased appetite (using slim fast)), FEELING ABNORMAL (Feeling not like myself), ALOPECIA (Hair thinnning), FATIGUE (Increased tiredness) and COVID-19 (COVID infection (delta variant)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product PALBOCICLIB (IBRANCE) tablet for Breast cancer.    No Medical History information was reported.   On 29-May-2021, the patient started PALBOCICLIB (IBRANCE) (Oral) 100 milligram once a day. In June 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In June 2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (Decreased appetite (using slim fast)), FEELING ABNORMAL (Feeling not like myself), ALOPECIA (Hair thinnning), FATIGUE (Increased tiredness) and COVID-19 (COVID infection (delta variant)). The patient was treated with FULVESTRANT (FASLODEX) at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (Decreased appetite (using slim fast)), FEELING ABNORMAL (Feeling not like myself), FATIGUE (Increased tiredness) and COVID-19 (COVID infection (delta variant)) outcome was unknown and ALOPECIA (Hair thinnning) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: blood work looked good.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  No concomitant medication was reported.  The patient experienced some symptoms of COVID-19 as runny nose (clear mucous), cough, sneezing. It was reported that for those symptoms ordered unspecified injections to help with recovery.  The patient was reported that throat congestion and cough had improved, but occurring only occasionally.  The reporter denied any missed dose.
On 1/20/21 approximately 8 hours after vaccine noticed redness, tenderness distal to injection site or right deltoid IM. Redness, tender/painful to touch increased over next 48 hours with area increasing in size. By Monday, less red, more pink and diffuse. Still tender to touch and painful it is now almost itch like feeling. I took 5 Zyrtec pills and a Pepcid through the course of 12 hrs. on Saturday as well as iced the red area. Only other treatment to date was putting hydrocortisone cream on it Sunday night. Plan on seeing either urgent care or Dermatologist today, 1/25. I have pictures but am unable to attach them. I can email them if someone will email me with the proper address.
pt presents to ED with history of having COVID 1 wk ago; increasing SOB; admitted with COVID pneumonia associated with acute encephalopathy; AKI; O2 sats in 70s on RA; O2 supplementation, ABX, Decadron; pt's condition worsened and he passed away in the hospital
Mild muscle and injection site pain on the 1st day. 2nd day, injection site and muscle pain in left upper arm. 3rd day fever to 99.8, fatigue,  general malaise, widespread muscle pain and soreness.  Development  of a new rash involving upper left arm slightly below the injection site. 4th day,  again a temperature to 99.0F, achy, general malaise and fatigue. Increased rash on upper left arm 8 inches in length by 4 inches in width, painful and hot to touch and swelling.   Treated with Benadryl and local steroids.   5day rash slowly resolving, no significant residual pain. Fever resolved, fatigue much improved.
This case was reported by a consumer and described the occurrence of transverse myelitis in a 37-year-old female subject who was vaccinated with BOOSTRIX, (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included seasonal allergy (the subject had no allergies to medication). Concurrent medications included ORTHO TRI-CYCLEN. On 26 March 2014, the subject received an unspecified dose of BOOSTRIX (0.5 ml, unknown route, left arm). On 20 April 2014, 25 days after vaccination with BOOSTRIX, the subject experienced constant humming and swimming sensation under the skin, pins and needles sensations, tingling sensation, numbing and stabbing sensation. These symptoms occurred in arms and legs. The subject also experienced complete acute bilateral neuropathy through arms and legs. On 23 April 2014, she was seen by her doctor. She had numerous testing and lab work done over the last 3 months and was diagnosed with post infection vaccine related transverse myelitis. This case was assessed as medically serious by GSK. On 18 August 2014, the subject started treatment with normal immunoglobulin (IVIG). She had 4 infusions so far. She could not pin point whether it was working yet. She was slated for 6 cycles (6 months). At the time of reporting, the events were unresolved.
Pt had FLUZONE HIGH DOSE about 5:30 pm and arm started hurting later Wed. evening. Still (as of Friday 10/01/10) warm, tender and red, splotchy areas under the injection site.
Shots received on 2/5/21 in office. Mom said that on Friday evening patient had shot rxn. On Friday pm/Sat am, he lost muscle control and his speaking ability. On Sunday, he had heartburn and then that changed to bundling pain below his sternum; like he is being punched. He still has that and with  that, he has decreased appetite. He was up around 8am on Sunday. He had breakfast burritos in the  am and Chipotle in the pm. He only ate some of it and that is all he had. He did ask on Monday about  dinner and seemed a bit hungry. Mom is encouraging fluids. Mom said that she does not want him to  have a second Meningitis B.
Swollen armpit; Left armpit became very painful to the touch; Left arm was sore; Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer, the patient. A 29-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm left on 31Mar2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation (Inappropriate schedule of vaccine administered). Medical history included swollen lymph nodes and breast cancer (reported as both sides of her family have breast cancer and issues with lymph nodes swelling). Patient received other medications in two weeks which included azurette (MANAFACTURER UNKNOWN) from an unspecified date for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the arm left on 14Mar2021 at 16:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies. On 31Mar2021, the patient experienced inappropriate schedule of vaccine administered, and on 01Apr2021 at 20:00, the patient experienced left arm was sore. Within 24 hours of receiving the shot, left armpit became very painful to the touch and was swollen. It had been 2 full days and it was still very painful. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Clinical outcomes of events axillary mass, armpit pain, pain in arm was not recovered. While, it was unknown for inappropriate schedule of vaccine administered.  No follow-up attempts are needed. No further information is expected.
Patient said she had arm pain starting the day after vaccination. She was diagnosed with SIRVA. The Dr prescribed Medrol Dosepack 4mg on 11/1/21.
12 hrs after vaccine was given pt c/o pain at site and warm, pink 2cm x 2cm area.  4/22 3.5cm area of redness, warm and hard to touch.  4/24 site of injection red and warm, erythema, induration; Augmentin 875mg q12hr x 7days prescribed for cellulitis at injection site.
0915 felt knot in throat.  0958 informed RN of knot in throat, rash on neck. 1000 EMS called  arrived at 1005 am. Rash progress to face No sneezing,SOA, coughing, or itching as stated by patient. Taken by EMS to ED treated with antihistamine, steroids, and discharged around 1330.States no c/o at this time.
1. Sinus infection and nasal infection (vestibulitis) - duration: ongoing and since after 1st shot.  Treatment from Allergist and ENT via budesonide, Azelastine, oral and topical antibiotics. 2. Injection site pain - duration 4 days - treatment was rest  3. Severe body aches - duration 1.5 days - treatment was rest and hydration 4. Skin on palms of hands shed - duration 1 day and took place 2 days after 2nd Covid shot, no treatment, resolved in one day.
Information has been received from a physician concerning a female "over 60 years old" who during the week of 22-OCT-2007 was vaccinated subcutaneously with a dose of ZOSTAVAX (Oka/Merck) (lot# 658604/1088U).  During the week of 22-OCT-2007 the patient experienced a 2 inch round, red swelling at the injection site.  It was unspecified if medical attention was sought.  No outcome was reported.  No product quality complaint was involved.  Additional information has been requested.
The patient received both immunizations and started to leave the store. A few minutes later she had walked back to the pharmacy. After checking on her, she was having an extremely difficult time breathing, could barely speak a couple of words. She tried to give herself a puff of albuterol and after a couple of minutes she was still having trouble breathing and had no improvement. 911 was called for assistance. I administered one dose of epinephrine into her right thigh. A few moments after the injection she was able to breathe without any difficulty. She did complain of hip pain post epihephrine but remained stable until EMS arrived.
Patient after being immunized feels dizzy and nauseated. Vital signs pulse 74, sat 98% B/P 110/70 Respirations 16, Dextro 108 by order of Doctor observed for 30 minutes at 4:45 the patient was reevaluated and discharged, vital signs were 100/60, breaths 18, pulse 98%, Right 108.
I have a swollen and painful lymph node on the left arm, where i received the vaccine shot.  Even though it has gotten a bit better, it is now the 5th day since the vaccine and i still have some discomfort.
This spontaneous report was received from a pharmacist concerning a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 15-SEP-2015, the patient was vaccinated with an expired dose of MMR II (Lot # JJ006995, expiration date 14-JUN-2015 (also reported) 12-JUL-2015) (dose and route not provided). Later, on the same day, the patient was vaccinated with another dose of MMR II (dose, route, lot No. were not provided). The reason was because they thought the expired dose would not count. Concomitant medications were not informed. No adverse event and product quality issue were involved it was unknown if the patient sought medical attention. Additional information has been requested.
booster dose administered out of vial punctured more than 12 hours; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (booster dose administered out of vial punctured more than 12 hours) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2022 at 1:10 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (booster dose administered out of vial punctured more than 12 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (booster dose administered out of vial punctured more than 12 hours) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.  Reporter Stated that, the vials were stored at room temperature post puncture and the vials did not undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8 degree Celsius to 25 degree Celsius are about 20 hours and 40 minutes.  Treatment details was not reported by the reporter.
Patient was due for the COVID-19 Pfizer 12 years and older booster. Patient inadvertently received a dose of the COVID-19 Pfizer 5-11 vaccine instead.
today she is extremely nauseous; she developed severe stomach pain; This is a spontaneous report from a contactable consumer (patient's daughter). A 74-year-old female patient received BNT162b2(PFIZERBIONTECH COVID-19 VACCINE Solution for injection, Lot Number and Expiry date: Unknown) via an unspecified route of administration on 21May2021 as 2nd dose, single for COVID-19 immunization. Historical vaccination included BNT162b2 (Dose Number-1, Batch/lot number: EW0177 Anatomical Location-Left Arm) on 30Apr2021 for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient daughter stated after received the second dose last Friday, 2 to 3 days later on 23May2021, her mother developed severe stomach pain last night and pain went away. On 24May2021, today she is extremely nauseous. The patient's daughter questioned that can a person develop side effects two to three days after getting the shot and stated otherwise her mother had food poisoning. The clinical outcome of the event stomach pain was recovered on 23May2021 and the event today she is extremely nauseous was not resolved.  Information on Lot/Batch number was available. Additional information has been requested.
Increased heart rate while asleep, highest BPM 114 detected by Apple Watch. Increased heart rate lasted about 2 hours. Intense neck and rib cage pain was also present during that time
It wasn't until Tuesday morning 09/28/2021 that I started feeling tired and achy. I had no fever, but I felt lethargic, and I laid down and didn't work that day and by Wednesday morning I felt much better and more like myself other than still having the aches and pain in injection site. It was very different from my first two vaccines. I was very sleepy and tired and fatigued, but by 09/29/2021 it was cleared up.
Sore arm (unusually sore for immunization), inflamed at injection site, feel hot to touch; 2nd day same symptoms plus had to leave work due to sickness, fever 102F; 3rd day feeling better, still a little puny but arm is still sore with a 3 sq inch inflamed area around the injection site which is hot to touch. I had none of these symptoms with the initial injection. I cannot remember ever having this type of reaction to any immunization. I have never been allergic to anything.
0.2ml of undiluted (not reconstituted) Pfizer Covid 5-11 yr olds vaccine administered to patient for her "booster"
Pt received Moderna for 1st dose and Pfizer for 2nd dose - as of 6-2-21 8pm, pt had reported no adverse event, told pt to get in touch with us if any issues, tried to contact pt again on 6-3-21 2pm
3 inch in diameter swelling  at site of injection; firm mass/welt at injection site; warm to touch that appeared about 24 hours after vaccination.  I thought it resolved after 48 hours of swelling, but then returned 9 days after vaccination.  The swelling is 3 inches in diameter, warm to touch & itchy, now 10 days after the vaccination.
Ice cold in veins immediately after the shot. The next day: fatigue, head pressure/cold. Strange heartbeat. 2 days later: muscle twitching (all over body), tingling in feet and palms. Tingling in palms resolved after a few days, but persisting on the bottom of a right foot 10 days after the injection (on the day of the reporting).
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history and concurrent condition were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of GARDASIL (dose and route of administration were not reported) lot #K007828; expiration date 02-MAR-2017. Concomitant medication was not reported. No adverse effect reported. There was not a product quality involved. This is one of the several reports from the same source. Additional information has been requested.
After my first shot it took, I woke up during the night and had a headache and felt lethargic .  These symptoms lasted about 4 to 5 days.  However they went away.  After my second shot, the same thing happened.  I woke up and had a bad headache and felt lethargic.  It has been 8 days and I still have a throbbing headache.  My primary care prescribed steroids.
Patient stated that she experienced redness and swelling at the site of injection and also a headache and possible fever (patient did not measure temperature). Patient sought prescriber assistance. Prescriber referred patient to the pharmacy. I counseled the patient that these are not unusual side effects of the vaccination. I also instructed the patient to take some TYLENOL for the pain, fever, and call us if the adverse symptoms do not improve or worsen. Patient stated understanding and was satisfied with the counseling received. Patient also stated that there was some improvement in the adverse reaction from yesterday 4/26/18 to today 4/27/18.
pt recv vax 3MAR98 & that same day pt exp fever & sore leg;tx w/APAP & is resolved;
Pt reports redness and warmth and itching to insertion site on left arm. 24 hours after administration. Patient see in clinic for assessment approximately 48 hours after administration. Patient also reported pain in axillary region. Enlarged lymphnodes noted.
Patient received Moderna Covid-19 Vaccine on 7-6-21 Patient received Pfizer Covid-19 Vaccine on 8-03-21
Fever developed about 3 hours after injection. Topped out at 100.7. Was gone by next morning. Next morning woke up at 7:00 am and was nauseous until around 12:00 noon.
Nausea, shivery chills, pain at injection site, headache, flu like feeling.  Extreme fatigue.
Narrative: hospitalized for CHF exacerbation (h/o CHF with EF 20%) on 2/2/21; received second dose after discharge; died 4/14 from CHF likely
Information has been received from a health professional concerning a patient in kindergarten who was vaccinated with a dose of Varivax. Subsequently the patient experienced chickenpox. Additional information has been requested.
Patient was hospitalized Feb 18th to the 21st and passed away on Feb 28, 2021.
Neurological changes,visual problems. Diagnosed as Multiple Sclerosis by ophtalmologist and neurologist. All after second dose of HPV (Gardasil) worsed after third dose. 10/14/08-records received-2/26/08-Admitting DX: Demyelinating Disease, left optic neuritis. Multiple Sclerosis-outpt records for lumbar puncture. Records for DOS 6/11-6/15/08-received-presented with acute exacerbation of MS, right lower extremity weakness and neuropathic pain. Migraine. Possible adverse reaction HPV vaccine and interferon. 1/26/2010 Multiple sclerosis, still in Tx.
chills, sweats, shakes, fever (101), hives, headache.  Shot received 5:00 PM Thursday, October 4, 2007. Symptoms appeared the following day, Friday, October 5, 2007 and progressed into the Friday evening when symptoms reach maximum and Saturday by 10 am, disappeared, except for the mild hives on my right shoulder which have remained
Cyproheptad 4mg Tab Teva. Methylpred 4 Mg Pak Qual. Several hours after receiving the flu vaccine severe itching started requiring medication for relief.